Drug addiction is a chronic relapsing disease with psychological and social factors. Compulsive drug-taking is the central feature of drug addiction. Understanding the molecular mechanisms underlying the transition between controlled drug use and the loss of control over drug-taking is crucial for developing methods for the prevention and treatment of drug addiction. The neurobiological mechanisms underlying the development of uncontrolled drug-taking behaviors are associated primarily with the brain mesocorticolimbic dopamine (DA) pathway. Moreover, changes in gene expression are thought to mediate, in part, the neuroadaptive responses to the development of cocaine-taking behaviors. However, the molecular determinants and their temporal and spatial involvement in the transition from initial drug use to compulsive drug-taking behaviors remain unidentified. Based on work from our own laboratory and from others, we hypothesize that DA D1 and D3 receptors and c-Fos play important roles in the transition between controlled cocaine use and escalated cocaine intake. We propose to generate novel mouse models in which the expression of D1, D3 receptor or c-fos genes can be temporally controlled in D1 receptor-expressing neurons respectively. We propose then to test the above hypothesis by turning off the expression of D1, D3 receptor or c-fos genes in these mice during the escalation or abstinence phases and then measuring cocaine intake in an escalating cocaine self-administration paradigm. Finally, we propose to identify c-Fos-regulated target genes that are involved in the transition between controlled cocaine use to escalated cocaine intake. Successful completion of the proposed work will provide valuable information for the temporal and spatial requirement of DA D1 and D3 receptors and c-Fos in the development of compulsive drug-taking behaviors. Identification of c-Fos-regulated molecular changes involved in the transition to escalated cocaine intake will pave the way for testing the physiological significance of these changes in cocaine-taking behaviors in the future. The combined use of genetically engineered mouse models with proper behavioral and molecular biological analyses has tremendous potential to provide novel insights into mechanisms underlying the development of drug addiction and new strategies for the treatment of drug abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
3R01DA014644-04S1
Application #
7086525
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Satterlee, John S
Project Start
2001-09-30
Project End
2007-02-28
Budget Start
2005-03-01
Budget End
2006-02-28
Support Year
4
Fiscal Year
2005
Total Cost
$29,060
Indirect Cost
Name
University of Cincinnati
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Liu, Xian-Yu; Mao, Li-Min; Zhang, Guo-Chi et al. (2009) Activity-dependent modulation of limbic dopamine D3 receptors by CaMKII. Neuron 61:425-38
Thomsen, Morgane; Han, Dawn D; Gu, Howard H et al. (2009) Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter. J Pharmacol Exp Ther 331:204-11
Thomsen, Morgane; Hall, F Scott; Uhl, George R et al. (2009) Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice. J Neurosci 29:1087-92
Hu, Xiu-Ti; Nasif, Fernando J; Zhang, Jianhua et al. (2008) Fos regulates neuronal activity in the nucleus accumbens. Neurosci Lett 448:157-60
Xu, Ming (2008) c-Fos is an intracellular regulator of cocaine-induced long-term changes. Ann N Y Acad Sci 1139:1-9
Caine, S Barak; Thomsen, Morgane; Gabriel, Kara I et al. (2007) Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. J Neurosci 27:13140-50
Jiao, Hongyuan; Zhang, Lu; Gao, Fenge et al. (2007) Dopamine D(1) and D(3) receptors oppositely regulate NMDA- and cocaine-induced MAPK signaling via NMDA receptor phosphorylation. J Neurochem 103:840-8
Pritchard, Laurel M; Newman, Amy Hauck; McNamara, Robert K et al. (2007) The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion. Pharmacol Biochem Behav 86:718-26
Thomsen, Morgane; Caine, S Barak (2007) Intravenous drug self-administration in mice: practical considerations. Behav Genet 37:101-18
Zhou, Yan; Adomako-Mensah, Johannes; Yuferov, Vadim et al. (2007) Effects of acute ""binge"" cocaine on mRNA levels of mu opioid receptor and neuropeptides in dopamine D1 or D3 receptor knockout mice. Synapse 61:50-9

Showing the most recent 10 out of 18 publications